Evidence map›Paper›PMID 40163550›Full record

ArticlePLoS computational biology2025

Putting computational models of immunity to the test-An invited challenge to predict B.pertussis vaccination responses.

Pramod Shinde, Lisa Willemsen, Michael Anderson, Minori Aoki, Saonli Basu, Julie G Burel, Peng Cheng, Souradipto Ghosh Dastidar, Aidan Dunleavy, Tal Einav and 49 more

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Is the vaccination-induced B cell receptor repertoire predictable?Immunoinformatics (Amsterdam, Netherlands) · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

59 authors.

Pramod ShindeCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.ORCID 0000-0002-1071-2744
Lisa WillemsenCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Michael AndersonDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.
Minori AokiCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Saonli BasuDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.
Julie G BurelCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Peng ChengDepartment of Molecular Biology, School of Biological Sciences, University of California, San Diego, La Jolla, California, United States of America.
Souradipto Ghosh DastidarDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.
Aidan DunleavySchool of Statistics, University of Minnesota, Minneapolis, Minnesota, United States of America.
Tal EinavCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Jamie ForschmiedtDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.
Slim FouratiDepartment of Medicine, Division of Allergy and Immunology, Feinberg School of Medicine and Center for Human Immunobiology, Northwestern University, Chicago, Illinois, United States of America.
Javier GarciaDepartment of Molecular Biology, School of Biological Sciences, University of California, San Diego, La Jolla, California, United States of America.
William GibsonVaccine Research Center, National Institute of Allergy and Infectious Disease, National Institute of Health, Bethesda, Maryland, United States of America.
Jason A GreenbaumLJI Bioinformatics Core, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Leying GuanDepartment of Biostatistics, Yale School of Public Health, New Haven, Connecticut, United States of America.
Weikang GuanDepartment of Molecular Biology, School of Biological Sciences, University of California, San Diego, La Jolla, California, United States of America.
Jeremy P GygiProgram in Computational Biology & Bioinformatics, Yale University, New Haven, Connecticut, United States of America.
Brendan HaLJI Bioinformatics Core, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Joe HouVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Jason HsiaoDepartment of Molecular Biology, School of Biological Sciences, University of California, San Diego, La Jolla, California, United States of America.ORCID 0000-0002-1663-9365
Yunda HuangVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Rick JansenBiostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0001-5683-2584
Bhargob KakotyDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.
Zhiyu KangDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.
James J KobieDepartment of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Mari KojimaCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Anna KonstorumDepartment of Pathology, Yale School of Medicine, New Haven, Connecticut, United States of America.
Jiyeun LeeCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Sloan A LewisCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Aixin LiDivision of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0009-0006-9319-8790
Eric F LockDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.
Jarjapu MahitaCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Marcus MendesCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Hailong MengDepartment of Pathology, Yale School of Medicine, New Haven, Connecticut, United States of America.
Aidan NeherDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.
Somayeh NiliCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Lars Rønn OlsenDepartment of Immunology and Microbiology, LEO Foundation Skin Immunology Research Center, University of Copenhagen, Copenhagen, Denmark.
Shelby OrfieldCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
James A OvertonKnocean, Inc., Toronto, Canada.ORCID 0000-0001-5139-5557
Nidhi PaiDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0003-0187-4407
Cokie ParkerNational Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, Maryland, United States of America.
Brian QianDepartment of Molecular Biology, School of Biological Sciences, University of California, San Diego, La Jolla, California, United States of America.
Mikkel RasmussenCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Joaquin ReynaCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, California, United States of America.ORCID 0000-0002-8468-2840
Eve RichardsonCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Sandra SafoDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.
Josey SorensonDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.
Aparna SrinivasanDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.
Nicola ThruppCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.ORCID 0000-0002-3495-6575
Rashmi TippalagamaCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Raphael TrevizaniCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Steffen VentzDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0003-2229-9560
Jiuzhou WangDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.
Cheng-Chang WuDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, Minnesota, United States of America.
Ferhat AyDepartment of Medicine, University of California San Diego, San Diego, California, United States of America.ORCID 0000-0002-0708-6914
Barry GrantDepartment of Molecular Biology, School of Biological Sciences, University of California, San Diego, La Jolla, California, United States of America.
Steven H KleinsteinProgram in Computational Biology & Bioinformatics, Yale University, New Haven, Connecticut, United States of America.
Bjoern PetersCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, United States of America.ORCID 0000-0002-8457-6693

Funding

SDMC: HIV Vaccine Trials NetworkUM1AI068635 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Peter B. Gilbert, Yunda Huang · 2011 to 2026
$385.9M
T follicular helper (Tfh) CD4+ T cell, germinal center, and antibody response dysfunction in human recurrent tonsillitisU19AI142742 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Shane P Crotty · 2019 to 2026
$32.8M
Developing computational models to predict the immune response to B. pertussis booster vaccinationU01AI150753 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI PETERS, BJOERN · 2020 to 2024
$7.1M
Identifying mechanisms and correlates of long-lasting vaccine-induced immunity to whooping coughU01AI141995 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI PETERS, BJOERN, SETTE, ALESSANDRO · 2019 to 2023
$4.1M
Towards a predictive understanding of influenza immunity through experimental data integration, iterative model development, and rigorous assessment of model qualityU01AI187062 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Bjoern Peters · 2025 to 2026
$2.5M
NIAID NIH HHS U01 AI141995NIAID NIH HHS U01 AI150753NIAID NIH HHS U01 AI187062NIAID NIH HHS U19 AI142742NIAID NIH HHS UM1 AI068635
6 · The paper itself

Abstract

Systems vaccinology studies have been used to build computational models that predict individual vaccine responses and identify the factors contributing to differences in outcome. Comparing such models is challenging due to variability in study designs. To address this, we established a community resource to compare models predicting B. pertussis booster responses and generate experimental data for the explicit purpose of model evaluation. We here describe our second computational prediction challenge using this resource, where we benchmarked 49 algorithms from 53 scientists. We found that the most successful models stood out in their handling of nonlinearities, reducing large feature sets to representative subsets, and advanced data preprocessing. In contrast, we found that models adopted from literature that were developed to predict vaccine antibody responses in other settings performed poorly, reinforcing the need for purpose-built models. Overall, this demonstrates the value of purpose-generated datasets for rigorous and open model evaluations to identify features that improve the reliability and applicability of computational models in vaccine response prediction.

Indexed as

Bordetella pertussisModels, ImmunologicalPertussis VaccineWhooping CoughAlgorithmsComputational BiologyComputer SimulationHumansVaccinationPertussis Vaccine

Identifiers

PMID40163550
PMCPMC11978014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.